Inventor · disambiguated record
Paolo Fiorina
Also filed as: FIORINA PAOLO
12 granted patents·19 pending applications·10 citations·filing 2014–2025
85Inventor score
Files withCHILDRENS MEDICAL CT CORP13OSPEDALE SAN RAFFAELE SRL7CHILDRENS MEDICAL CENTER3ENTHERA S R L3NEPHRIS SRL2
Top patents by PatentIndex Score
31 records- 0189US11020453B2Inhibitor of IGFBP3/TMEM219 axis and diabetesOSPEDALE SAN RAFFAELE SRL·Filed 2018·Granted Jun 1, 2021·4 cites·22 claims
- 0289US2025333702A1Cells with increased immuno-regulatory properties and methods for their use and manufactureCHILDRENS MEDICAL CT CORP·Filed 2024·Application pending·0 cites
- 0387US2025101381A1Cells with increased immuno-regulatory properties and methods for their use and manufactureCHILDRENS MEDICAL CT CORP·Filed 2024·Application pending·0 cites
- 0486US10682391B2Inhibitors of IGFBP3 binding to TMEM219 for treatment of intestinal diseasesOSPEDALE SAN RAFFAELE SRL·Filed 2016·Granted Jun 16, 2020·4 cites·10 claims
- 0583US10751373B2PD-L1 expressing hematopoietic stem cells and usesTHE CHILDREN'S MEDICAL CENTER CORP·Filed 2019·Granted Aug 25, 2020·1 cites·19 claims
- 0680US2023002733A1Cells with increased immuno-regulatory properties and methods for their use and manufactureCHILDRENS MEDICAL CT CORP·Filed 2022·Application pending·0 cites
- 0780US2023321150A1Pd-l1 expressing hematopoietic stem cells and usesCHILDRENS MEDICAL CT CORP·Filed 2023·Application pending·0 cites
- 0879US2025228805A1Prevention and treatment of diabetic nephropathyCHILDRENS MEDICAL CT CORP·Filed 2024·Application pending·0 cites
- 0977US11291641B2Prevention and treatment of diabetic nephropathyCHILDRENS MEDICAL CT CORP·Filed 2017·Granted Apr 5, 2022·1 cites·20 claims
- 1074US12097172B2Prevention and treatment of diabetic nephropathyCHILDRENS MEDICAL CT CORP·Filed 2022·Granted Sep 24, 2024·0 cites·20 claims
- 1174US2020102540A1Cells with increased immuno-regulatory properties and methods for their use and manufactureCHILDRENS HOSPITAL CORP·Filed 2019·Application pending·0 cites
- 1272US11642378B2PD-L1 expressing hematopoietic stem cells and usesCHILDRENS MEDICAL CT CORP·Filed 2019·Granted May 9, 2023·0 cites·13 claims
- 1372US10517899B2PD-L1 expressing hematopoietic stem cells and usesCHILDRENS MEDICAL CT CORP·Filed 2018·Granted Dec 31, 2019·0 cites·19 claims
- 1470US2023218775A1Method of preventing and treating type 1 diabetes, allograft rejection and lung fibrosis (by targeting the atp/p2x7r axis)CHILDRENS MEDICAL CENTER·Filed 2022·Application pending·0 cites
- 1569US12221485B2TMEM219 antibodies and therapeutic uses thereofENTHERA S R L·Filed 2024·Granted Feb 11, 2025·0 cites·22 claims
- 1668US2025346656A1Methods for treating diabetic kidney disease and glomerular diseaseNEPHRIS SRL·Filed 2025·Application pending·0 cites
- 1767US11452781B2Method of preventing and treating type 1 diabetes, allograft rejection and lung fibrosis (by targeting the ATP/P2X7R axis)CHILDRENS MEDICAL CENTER·Filed 2018·Granted Sep 27, 2022·0 cites·3 claims
- 1867US10071167B2Method of preventing and treating type 1 diabetes, allograft rejection and lung fibrosis (by targeting the ATP/P2X7R axis)CHILDRENS MEDICAL CENTER·Filed 2014·Granted Sep 11, 2018·0 cites·2 claims
- 1967US2021169973A1Inhibitor of IGFBP3/TMEM219 Axis and DiabetesOSPEDALE SAN RAFFAELE SRL·Filed 2021·Application pending·0 cites
- 2063US2025346652A1Methods for treating diabetic kidney disease and glomerular diseaseNEPHRIS SRL·Filed 2022·Application pending·0 cites
- 2162US2018214487A1Pd-l1 expressing hematopoietic stem cells and usesCHILDRENS MEDICAL CT CORP·Filed 2016·Application pending·0 cites
- 2261US2025129093A1Compositions and methods relating to atp/p2x7r signaling inhibitionCHILDRENS MEDICAL CT CORP·Filed 2023·Application pending·0 cites
- 2359US12221476B2Antibodies and uses thereofOSPEDALE SAN RAFFAELE SRL·Filed 2019·Granted Feb 11, 2025·0 cites·22 claims
- 2457US2024165223A1Vaccine composition comprising a leishmania host cell expressing at least one protein of the family coronaviridaeUNIV DEGLI STUDI DI MILANO 90%·Filed 2022·Application pending·0 cites
- 2556US2018169184A1Inhibitor of IGFBP3/TMEM219 Axis and DiabetesOSPEDALE SAN RAFFAELE SRL·Filed 2016·Application pending·0 cites
- 2655US2020316168A1Inhibitors of igfbp3 binding to tmem219 for treatment of intestinal diseasesOSPEDALE SAN RAFFAELE SRL·Filed 2020·Application pending·0 cites
- 2753US2024024361A1Methods and compositions for treating multiple sclerosisCHILDRENS MEDICAL CT CORP·Filed 2021·Application pending·0 cites
- 2850US2025270306A1Antibodies and uses thereofOSPEDALE SAN RAFFAELE SRL·Filed 2025·Application pending·0 cites
- 2948US11879137B2Treatment of type 1 diabetes and autoimmune diseases or disordersCHILDRENS MEDICAL CT CORP·Filed 2018·Granted Jan 23, 2024·0 cites·16 claims
- 3046US2023242649A1Tmem219 antibodies and therapeutic uses thereofENTHERA S R L·Filed 2020·Application pending·0 cites
- 3139US2023039165A1Igfbp3 antibodies and therapeutic uses thereofENTHERA S R L·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paolo Fiorina files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →